eFoodSafety.com, Inc. Announces Cinnergen(TM) Sales Gaining Momentum

Newsletter

May 1, 2007

Volume VIII, Issue 31

Home Page : www.otcjournal.com
Email Questions or Comments To: editor@otcjournal.com

To OTC Journal Members:

eFoodSafety (OTC BB: EFSF): Takes the B Out of Boredom

OK stocks- time to wake up from your two month nap. Haven't seen much of the OTC Journal lately? There's a reason for that- not much to report. For some reason, we seem to have entered some sort of news vacuum on the current followings. NIHK running up to $.24 is now yesterday's news, and I hope you all locked in some profits. Some of you might be asking what have I done for you lately.

Thank you EFSF for delivering- it could be the next breakout stock. If you took my April 10 BLOG to heart and accumulated this stock while it was quiet and no one wanted it- it's about to get loud again. If you acted in the last few weeks, you are learning how to trade.

As many of you know, I am a believer in their Cinnergen product. A cap full of this product helps control blood sugar levels and can reduce or eliminate the need for insulin in diabetics. A clinical study proved it, and retailers are now lining up to carry the product. WalMart joined the party last month, and we'll see more big names over time.

There are a couple of developments to report on this product. First- if you read the press release a week ago, you can start watching "The Price Is Right" for Cinnergen commercials. Check your local listings- I don't know when it's on.

Secondly- I have a special treat- a "first look" for OTC Journal subscribers. There is a short feature on the product- a news report. It will be distributed to local TV stations and media outlets all over the country. Of course- I have a link for you to view it:

Click Here to view the news feature on Cinnergen, or go to the following URL: http://www.usngonline.com/images/cinnergen.wmv

It's a very compelling story, and if you agree you need to own the stock.

In addition, pre open today, EFSF published a news release confirming Cinnergen sales have shown double digit increases throughout the month of April. The product is now really started to get traction in the retail stores. Their next financial filing should show huge top line percentage increases.

There's a lot to like about today's news. For one thing, if history repeats itself, EFSF will trade very well on this news. For a small stock, this company has a lot of believers- the loyal shareholder base tends to jump in when the company delivers positive developments.

Secondly, I love the way the stock has traded sideways right on the .618% retracement line for over a month. The volume has dried up. In short, everyone who wanted to sell this stock has had ample opportunity to do so. This stock should trade very well on today's news.

Thirdly, and perhaps most important from my point of view, is another event buried down towards the bottom of the news. Pat Gruden, CEO of the company, reports EFSF "anticipate(s) reporting dramatic improvements in the company’s balance sheet within the next 30 days.”

I also love this news. As many of you know who have read my reporting on EFSF, I had concerns about the company's balance sheet in their last financial reporting. In short, debt and cash pretty much matched. I like to cover companies who have the money they need to execute on their business plan. Balance sheet improvements would be welcome news on the risk side of the equation.

In my view, this stock is absolutely poised to run up. If you don't own as much as you want, and can still pick it up under $.40 by the time you read this, do so.

Here is the complete text of today's news for your review:

Press Release Source: eFoodSafety.com, Inc.

eFoodSafety.com, Inc. Announces Cinnergen(TM) Sales Gaining Momentum

Tuesday May 1, 9:45 am ET

Cinnergen(TM) Weekly Sales Beginning to Show Double Digit Increases Throughout April

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--eFoodSafety.com, Inc. (OTCBB: EFSF - News), a Company dedicated to improving health conditions around the world through innovative products and technologies, today announced that the sales of Cinnergen(TM), the Company's all-natural dietary supplement clinically proven to promote healthy glucose metabolism and lower blood sugar levels in as little as 7 days, are gaining momentum while showing consistent double-digit weekly sales increases.

The Company also announced its national advertising campaign is scheduled to launch next week corresponding with Cinnergen(TM) being featured in one of the pricing games on The Price is Right. The Price is Right, televised by CBS, is seen nationwide Monday through Friday by an estimated 5.8 million people.

Patricia Gruden, President and CEO of eFoodSafety.com, Inc., stated, "We are pleased to be realizing the eagerly awaited tangible results of many long hours of hard work. Product sales through our national retail distribution network are increasing and gaining the anticipated weekly momentum and our catalog sales continue to show strong growth. Our previously stated goal of having Cinnergen(TM) in over 20,000 retail locations by year is not only on track but it's happening faster than originally anticipated."

Gruden further commented, "I believe the investment community and our valued shareholders will soon come to realize that the Company's previous investments in product development and infrastructure, although impacting near-term profitability, will result in the creation of long term sustainable value. We anticipate reporting dramatic improvements in the company's balance sheet within the next 30 days."

About eFoodSafety.com, Inc.

eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn(TM)-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn(TM) line. The Company is also owner of Cinnergen(TM), a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com) and Cinnechol(TM), a new multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The Company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect(TM) anti-acne skin care system.

Please visit the Company's website at: http://www.efoodsafety.com.

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.

Contact:

Redwood Consultants, LLC
Jens Dalsgaard, 415-884-0348

Source: eFoodSafety.com, Inc.

Subscribe

Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.

Disclaimer

The OTCjournal.com Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. Moreover, as detailed below, this publication accepts compensation from certain of the companies which it features. Likewise, this newsletter is owned by MarketByte, LLC. To the degrees enumerated herein, this newsletter should not be regarded as an independent publication.

Go Here to view our compensation on every company we have ever covered, or visit the following web address: http://www.otcjournal.com/disclaimer.html for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html for Trading Alerts. MarketByte LLC has been paid a fee of $30,000 cash and 1 million newly issued restricted shares by eFoodSafety for coverage of the company.

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

From time to time MarketByte LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.

The editor, members of the editor's family, and/or entities with which they are affiliated aside from MarketBtye LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter. Some of the companies featured in the OTC Journal pay a cash ESP fee to an affiliated technology company ranging from $2,000 to $5,000 per month for internet related technology services.

The Trustee of the MarketByte LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately The Trustee of the MarketByte LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $310,0000 in the Longview Fund (“the Longview Limited Partnership”), a limited partnership in which the MarketByte Pension Plan is a limited partner. No one associated with the MarketByte Pension Plan has any knowledge, information, or control as to any past, present, or future investment activities of the Longview Fund. Longview ocassoinally refers companies to MarketByte LLC for possible coverage by one of the MarketByte LLC publications, which publications include The OTCJournal.com Newsletter. Longview may or may not own shares in the companies that it so refers to MarketByte. MarketByte has no information (outside of information readily accessible to the general public such as SEC filings) as to whether Longview owns any shares in the companies that it refers to MarketByte LLC. The above relationships should be viewed as a potential and/or actual conflict of interest by shareholders and prospective shareholders of MarketByte LLC client companies.

The profiles, critiques, and other editorial content of the OTCjournal.com may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCjournal.com.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID:$subst('Recip.userid') Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site. MarketByte LLC's mailing address is 4653 Carmel Mtn Rd Suite 308 #402, San Diego, CA 92130.

You can unsubscribe from this list at any time by Clicking Here and HITTING SEND. If you are having difficulty removing yourself or wish to change your address please go to http://listserv.otcjournal.com/opt.cgi?.